Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy.

Ortega-García MB, Mesa A, Moya ELJ, Rueda B, Lopez-Ordoño G, García JÁ, Conde V, Redondo-Cerezo E, Lopez-Hidalgo JL, Jiménez G, Peran M, Martínez-González LJ, Del Val C, Zwir I, Marchal JA, García MÁ.

Cancers (Basel). 2020 Feb 7;12(2). pii: E379. doi: 10.3390/cancers12020379.

2.

Bio-inspired hydrogel composed of hyaluronic acid and alginate as a potential bioink for 3D bioprinting of articular cartilage engineering constructs.

Antich C, de Vicente J, Jiménez G, Chocarro C, Carrillo E, Montañez E, Gálvez-Martín P, Marchal JA.

Acta Biomater. 2020 Feb 3. pii: S1742-7061(20)30064-7. doi: 10.1016/j.actbio.2020.01.046. [Epub ahead of print]

3.

Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients.

Farace C, Pisano A, Griñan-Lison C, Solinas G, Jiménez G, Serra M, Carrillo E, Scognamillo F, Attene F, Montella A, Marchal JA, Madeddu R.

Oncotarget. 2020 Jan 14;11(2):116-130. doi: 10.18632/oncotarget.27411. eCollection 2020 Jan 14.

4.

miRNAs as radio-response biomarkers for breast cancer stem cells.

Griñán-Lisón C, Olivares-Urbano MA, Jiménez G, López-Ruiz E, Del Val C, Morata-Tarifa C, Entrena JM, González-Ramírez AR, Boulaiz H, Zurita Herrera M, Núñez MI, Marchal JA.

Mol Oncol. 2020 Jan 13. doi: 10.1002/1878-0261.12635. [Epub ahead of print]

5.

Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance.

Yaiza JM, Gloria RA, María Belén GO, Elena LR, Gema J, Juan Antonio M, María Ángel GC, Houria B.

Tissue Cell. 2019 Oct;60:48-59. doi: 10.1016/j.tice.2019.07.005. Epub 2019 Aug 3.

PMID:
31582018
6.

LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy.

Jiménez-Martínez Y, Griñán-Lisón C, Khaldy H, Martín A, Cambrils A, Ibáñez Grau A, Jiménez G, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1016. doi: 10.3390/cancers11071016.

7.

A soft 3D polyacrylate hydrogel recapitulates the cartilage niche and allows growth-factor free tissue engineering of human articular cartilage.

Jiménez G, Venkateswaran S, López-Ruiz E, Perán M, Pernagallo S, Díaz-Monchón JJ, Canadas RF, Antich C, Oliveira JM, Callanan A, Walllace R, Reis RL, Montañez E, Carrillo E, Bradley M, Marchal JA.

Acta Biomater. 2019 May;90:146-156. doi: 10.1016/j.actbio.2019.03.040. Epub 2019 Mar 22.

PMID:
30910621
8.

Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin.

Cáceres B, Ramirez A, Carrillo E, Jimenez G, Griñán-Lisón C, López-Ruiz E, Jiménez-Martínez Y, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Feb 23;11(2). pii: E264. doi: 10.3390/cancers11020264.

9.

Excess Hydrocortisone Hampers Placental Nutrient Uptake Disrupting Cellular Metabolism.

Mateos RM, Jiménez G, Álvarez-Gil C, Visiedo F, Rivera-Rodríguez F, Santos-Rosendo C, Rodriguez-Pareja A, Perdomo G, Lechuga-Sancho AM.

Biomed Res Int. 2018 Oct 9;2018:5106174. doi: 10.1155/2018/5106174. eCollection 2018.

10.

Revisiting the dynamic cancer stem cell model: Importance of tumour edges.

Hernández-Camarero P, Jiménez G, López-Ruiz E, Barungi S, Marchal JA, Perán M.

Crit Rev Oncol Hematol. 2018 Nov;131:35-45. doi: 10.1016/j.critrevonc.2018.08.004. Epub 2018 Aug 28. Review.

PMID:
30293704
11.

Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells.

Ramírez A, Conejo-García A, Griñán-Lisón C, López-Cara LC, Jiménez G, Campos JM, Marchal JA, Boulaiz H.

Front Pharmacol. 2018 Jul 26;9:798. doi: 10.3389/fphar.2018.00798. eCollection 2018.

12.

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.

González-González A, Muñoz-Muela E, Marchal JA, Cara FE, Molina MP, Cruz-Lozano M, Jiménez G, Verma A, Ramírez A, Qian W, Chen W, Kozielski AJ, Elemento O, Martín-Salvago MD, Luque RJ, Rosa-Garrido C, Landeira D, Quintana-Romero M, Rosato RR, García MA, Ramirez-Tortosa CL, Kim H, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Lorente JA, Sánchez-Rovira P, Chang JC, Granados-Principal S.

Clin Cancer Res. 2018 Nov 15;24(22):5697-5709. doi: 10.1158/1078-0432.CCR-17-3125. Epub 2018 Jul 16.

13.

Models of Disease.

Jiménez G, López-Ruiz E, Antich C, Chocarro-Wrona C, Marchal JA.

Adv Exp Med Biol. 2018;1059:331-350. doi: 10.1007/978-3-319-76735-2_15.

PMID:
29736581
14.

Osteoarthritis: Trauma vs Disease.

Jiménez G, Cobo-Molinos J, Antich C, López-Ruiz E.

Adv Exp Med Biol. 2018;1059:63-83. doi: 10.1007/978-3-319-76735-2_3. Review.

PMID:
29736569
15.

Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile.

Jiménez G, Hackenberg M, Catalina P, Boulaiz H, Griñán-Lisón C, García MÁ, Perán M, López-Ruiz E, Ramírez A, Morata-Tarifa C, Carrasco E, Aguilera M, Marchal JA.

Cancer Lett. 2018 Aug 10;429:78-88. doi: 10.1016/j.canlet.2018.04.042. Epub 2018 May 5.

PMID:
29733965
16.

Poly(ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial re-population, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement.

López-Ruiz E, Venkateswaran S, Perán M, Jiménez G, Pernagallo S, Díaz-Mochón JJ, Tura-Ceide O, Arrebola F, Melchor J, Soto J, Rus G, Real PJ, Diaz-Ricart M, Conde-González A, Bradley M, Marchal JA.

Sci Rep. 2017 Mar 24;7(1):407. doi: 10.1038/s41598-017-00294-6.

17.

Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?

López-Ruiz E, Jiménez G, García MÁ, Antich C, Boulaiz H, Marchal JA, Perán M.

Expert Opin Ther Pat. 2016 Aug;26(8):877-90. doi: 10.1080/13543776.2016.1203903. Epub 2016 Jul 8. Review.

PMID:
27337937
18.

Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.

Morata-Tarifa C, Jiménez G, García MA, Entrena JM, Griñán-Lisón C, Aguilera M, Picon-Ruiz M, Marchal JA.

Sci Rep. 2016 Jan 11;6:18772. doi: 10.1038/srep18772.

19.

HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.

Ramírez A, Boulaiz H, Morata-Tarifa C, Perán M, Jiménez G, Picon-Ruiz M, Agil A, Cruz-López O, Conejo-García A, Campos JM, Sánchez A, García MA, Marchal JA.

Oncotarget. 2014 Jun 15;5(11):3590-606.

20.

Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence.

Marchal JA, Carrasco E, Ramirez A, Jiménez G, Olmedo C, Peran M, Agil A, Conejo-García A, Cruz-López O, Campos JM, García MÁ.

Drug Des Devel Ther. 2013 Oct 29;7:1301-13. doi: 10.2147/DDDT.S51354. eCollection 2013.

Supplemental Content

Loading ...
Support Center